Explore more publications!

Press Releases

New State-by-State Analysis Reveals Where America’s 2 Trillion Dollar Burnout Crisis Hits Hardest
NeurAxis Announces New Medical Policy Coverage in Michigan, Adding 566,000 Covered Lives
EGLE kicks off manganese occurrence study, to sample water in 41 Michigan counties

EGLE kicks off manganese occurrence study, to sample water in 41 Michigan counties

Advance in Dietary Assessment Powers New Approach to Nutrition Research, Programming
AHA leadership to discuss AI, public-private partnerships and more during 48th World Hospital Congress in Switzerland 
The Health Care Transformation Task Force Welcomes Two New Members
Rivertown Ridge Joins the CPF Living and Grace Management, Inc. Family of Senior Living Communities
Elwart Family Chiropractic Introduces Shockwave Therapy in Clinton Township, Michigan
Entrepreneurs in Louisiana are Invited to Join Synchrocare’s Growing Medical Device Franchise Network
Influential Women Spotlights Shay Wintz: A Beacon of Education and Wellness in Kalamazoo
WITCH’S RECOVERY CIRCLE OPENS CALL FOR GUEST SPEAKERS AND GLOBAL COLLABORATORS
LIFE Delivers Lifesaving Medical Aid to Over 15,000 People in Sub-Saharan Africa
NURSE SENTENCED FOR TAMPERING WITH VIALS OF FENTANYL

NURSE SENTENCED FOR TAMPERING WITH VIALS OF FENTANYL

Entrepreneurs in Arkansas are Invited to Join Synchrocare’s Growing Medical Device Franchise Network
EZE Launches Innovative White-Glove Home-Sale Support to Help SW Michigan Homeowners Keep More Equity
Uptiv Health Expands Virtual Chronic Care  Services Through Strategic Partnership with Harmonic Health
Veterans Month Medication and Suicide Prevention Event Hosted at Michigan State Capitol November 5
$1.84 million in grants grow Michigan’s EV charging infrastructure

$1.84 million in grants grow Michigan’s EV charging infrastructure

Ascentage Pharma to Present Data from Multiple Studies of Olverembatinib, Including the First Dataset from POLARIS-1 Study, at ASH 2025
Ascentage Pharma to Present Data from Two Clinical Studies for Bcl-2 Inhibitor Lisaftoclax, Including an Oral Report, at ASH 2025

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions